Canaccord lowered the firm’s price target on TTEC Holdings to $4.50 from $8 and keeps a Hold rating on the shares. The firm said the company’s Q2 print was shy of expectations and full-year guidance was lowered due to some transitional issues in the healthcare vertical within the company’s engage business, delay in a public sector go-live, and voluntarily exiting some programs that did not quite fit within the company’s overall strategic direction.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TTEC:
Questions or Comments about the article? Write to editor@tipranks.com